Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Current HIV Research|February 3, 2007
Identification of cross-neutralization determinants by GAP analysis: a mutational behavior approachFusheng Li, Peter B Gilbert, Steve G SelfStatistics in Biopharmaceutical Research|January 15, 2010
Simultaneous Evaluation of the Magnitude and Breadth of a Left and Right Censored Multivariate Response, with Application to HIV Vaccine DevelopmentYunda Huang, Peter B Gilbert, David C Montefiori, et al.Current HIV Research|February 3, 2007
HIV-1 CTL-based vaccine immunogen selection: antigen diversity and cellular response featuresFusheng Li, Helen Horton, Peter B Gilbert, et al.Clinical Investigation|December 18, 2012
HIV Vaccine Trials Network: activities and achievements of the first decade and beyondJames G Kublin, Cecilia A Morgan, Tracey A Day, et al.The Journal of Infectious Diseases|July 9, 2010
Magnitude and breadth of a nonprotective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccinePeter Gilbert, Maggie Wang, Terri Wrin, et al.Journal of Immunological Methods|September 8, 2012
Optimization and qualification of an 8-color intracellular cytokine staining assay for quantifying T cell responses in rhesus macaques for pre-clinical vaccine studiesMitzi M Donaldson, Shing-Fen Kao, Leila Eslamizar, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 7, 2007
Inclusion of adolescents in preventive HIV vaccine trials: public health policy and research design at a crossroadsHeather B Jaspan, Coleen K Cunningham, Tim J P Tucker, et al.Journal of Virology|November 27, 2009
Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodiesMichael S Seaman, Holly Janes, Natalie Hawkins, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2006
Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trialNina D Russell, Barney S Graham, Michael C Keefer, et al.Nature Medicine|September 1, 2015
HIV-1 infections with multiple founders are associated with higher viral loads than infections with single foundersHolly Janes, Joshua T Herbeck, Sodsai Tovanabutra, et al.Pageof 2